FinancialContent is the trusted provider of stock market information to the media industry.
Sarepta's Upside Story Is Just Getting Started
October 02, 2017
3 Reasons To Like Vertex Pharma Shares
September 29, 2017
2017 on Track to be a Record Breaking Year for Orphan Drug Approvals
September 08, 2017
Shire: Innovative Therapies for Rare Diseases
September 01, 2017
category Pharma News, Research & Solutions , Health & Healthcare , Healthcare Innovation , and 4 more.
Ultragenyx Discontinues Phase 3 GNE Myopathy Study
August 23, 2017
Delivering Outstanding Rare Care: Q&A Released with Rare Disease revolutioner, Larissa Kerecuk, Ahead of Orphan Drugs Conference
August 15, 2017
Rare Diseases Get Their Turn in the Spotlight
April 21, 2017
4 Insects Used to Treat Wounds and Diseases
April 12, 2017
Improving Diagnostic Pathways for Rare Disease Patients
April 10, 2017
Shire Issues 2016 Annual Responsibility Review
March 23, 2017
Gene Therapy for Rare Diseases: Challenges & opportunities explored by Genetic Alliance UK, Chiesi Farmaceutici, Horizon Pharma & Alexion Pharma Int
March 21, 2017
Shire and SeriousFun: Our First Year Together
February 27, 2017
The Worst Disease You’ve Never Heard of is Just as Common as Cystic Fibrosis and ALS
February 09, 2017
Orphan Drugs: What Are They?
November 03, 2016
Retrophin Up 40% On Kidney Disease Drug Trial, Shkreli Still Wants His $25+ Million 'Hogan Reward'
September 07, 2016
Sanofi Is Looking For Rare Disease Acquisitions, FT Says
February 29, 2016
Rare Diseases Are Not That Rare
February 29, 2016
BioCryst Pharmaceuticals Is Plummeting 65%
February 08, 2016
Debunking Common Brain Cancer Myths
November 05, 2015
Cure SMA Releases Statement on 21st Century Cures
January 28, 2015
Stock Market JSON API provided by www.cloudquote.net
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial